意大利年轻成年人(20-49 岁)癌症发病率的时间趋势。一项基于人口的研究,2008-2017 年。

IF 2 4区 医学 Q3 ONCOLOGY
Tumori Pub Date : 2024-11-15 DOI:10.1177/03008916241297078
Fabrizio Stracci, Diego Serraino, Mario Fusco, Walter Mazzucco, Sabrina Fabiano, Andrea Tittarelli, Viviana Perotti, Luigino Dal Maso, Manuel Zorzi, Enrica Migliore, Margherita Ferrante, Cinzia Gasparotti, Silvia Ghisleni, Rossella Cavallo, Maria Teresa Pesce, Claudia Casella, Paola Ballotari, Rocco Galasso, Federica Manzoni, Eugenia Spata, Maria Adalgisa Gentilini, Francesca Bella, Anna Clara Fanetti
{"title":"意大利年轻成年人(20-49 岁)癌症发病率的时间趋势。一项基于人口的研究,2008-2017 年。","authors":"Fabrizio Stracci, Diego Serraino, Mario Fusco, Walter Mazzucco, Sabrina Fabiano, Andrea Tittarelli, Viviana Perotti, Luigino Dal Maso, Manuel Zorzi, Enrica Migliore, Margherita Ferrante, Cinzia Gasparotti, Silvia Ghisleni, Rossella Cavallo, Maria Teresa Pesce, Claudia Casella, Paola Ballotari, Rocco Galasso, Federica Manzoni, Eugenia Spata, Maria Adalgisa Gentilini, Francesca Bella, Anna Clara Fanetti","doi":"10.1177/03008916241297078","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate short-term (2008-2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and cancer type.</p><p><strong>Methods: </strong>Observational study from population-based data collected by 20 Italian Cancer Registries, covering 33% of the Italian population. The age-standardized incidence rates (ASRs), overall and stratified by area, sex, cancer site or type, and major age groups (i.e., 20-39, 40-49), were computed.</p><p><strong>Results: </strong>In 2008-2017, cancer incidence rates were almost two times higher in Italian women aged 20-49 than in age-corresponding men (202.2 vs 112.4 per 100,000) on account of elevated rates of breast and thyroid cancers. Contrasting trends emerged according to cancer sites/types. ASRs for female breast cancer increased steadily from 2008 (82.4) to 2014 (86.2) and remained unchanged thereafter (i.e., 86.5 in 2017). During the study period, there was an increase for testicular cancer, skin melanoma in both sexes, and thyroid cancer until 2013 (followed by a slight decrease from 2014 to 2017). Conversely, ASRs consistently declined for colorectal cancer and were substantially stable or slightly decreasing for cervix uteri (from 8.1 to 7.7), ovary (from 7.5 to 6.9) and non-Hodgkin lymphoma (from 8.3 to 7.6 in men and from 5.9 to 5.5 in women).</p><p><strong>Conclusions: </strong>Study findings do not support a unique temporal pattern for the incidence of early-onset cancer in Italy until 2017, as reported in other countries. Increases in incidence documented in both sexes for some tumor sites was counterbalanced by a decrease in other sites. The importance of supporting prevention strategies from the youngest of ages must be emphasized, and the role of anticipated screening should be carefully addressed.</p>","PeriodicalId":23349,"journal":{"name":"Tumori","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-2017.\",\"authors\":\"Fabrizio Stracci, Diego Serraino, Mario Fusco, Walter Mazzucco, Sabrina Fabiano, Andrea Tittarelli, Viviana Perotti, Luigino Dal Maso, Manuel Zorzi, Enrica Migliore, Margherita Ferrante, Cinzia Gasparotti, Silvia Ghisleni, Rossella Cavallo, Maria Teresa Pesce, Claudia Casella, Paola Ballotari, Rocco Galasso, Federica Manzoni, Eugenia Spata, Maria Adalgisa Gentilini, Francesca Bella, Anna Clara Fanetti\",\"doi\":\"10.1177/03008916241297078\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate short-term (2008-2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and cancer type.</p><p><strong>Methods: </strong>Observational study from population-based data collected by 20 Italian Cancer Registries, covering 33% of the Italian population. The age-standardized incidence rates (ASRs), overall and stratified by area, sex, cancer site or type, and major age groups (i.e., 20-39, 40-49), were computed.</p><p><strong>Results: </strong>In 2008-2017, cancer incidence rates were almost two times higher in Italian women aged 20-49 than in age-corresponding men (202.2 vs 112.4 per 100,000) on account of elevated rates of breast and thyroid cancers. Contrasting trends emerged according to cancer sites/types. ASRs for female breast cancer increased steadily from 2008 (82.4) to 2014 (86.2) and remained unchanged thereafter (i.e., 86.5 in 2017). During the study period, there was an increase for testicular cancer, skin melanoma in both sexes, and thyroid cancer until 2013 (followed by a slight decrease from 2014 to 2017). Conversely, ASRs consistently declined for colorectal cancer and were substantially stable or slightly decreasing for cervix uteri (from 8.1 to 7.7), ovary (from 7.5 to 6.9) and non-Hodgkin lymphoma (from 8.3 to 7.6 in men and from 5.9 to 5.5 in women).</p><p><strong>Conclusions: </strong>Study findings do not support a unique temporal pattern for the incidence of early-onset cancer in Italy until 2017, as reported in other countries. Increases in incidence documented in both sexes for some tumor sites was counterbalanced by a decrease in other sites. The importance of supporting prevention strategies from the youngest of ages must be emphasized, and the role of anticipated screening should be carefully addressed.</p>\",\"PeriodicalId\":23349,\"journal\":{\"name\":\"Tumori\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tumori\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/03008916241297078\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03008916241297078","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估意大利 20-49 岁人群癌症发病率的短期(2008-2017 年)趋势:按性别和癌症类型评估意大利 20-49 岁人群癌症发病率的短期(2008-2017 年)趋势:观察性研究来自 20 个意大利癌症登记处收集的人口数据,覆盖 33% 的意大利人口。计算了总体年龄标准化发病率(ASR),以及按地区、性别、癌症部位或类型和主要年龄组(即 20-39 岁、40-49 岁)进行的分层年龄标准化发病率(ASR):2008-2017年,由于乳腺癌和甲状腺癌发病率上升,20-49岁意大利女性的癌症发病率几乎是同年龄男性的两倍(每10万人中202.2人对112.4人)。不同癌症部位/类型的趋势截然不同。女性乳腺癌的ASR从2008年(82.4)稳步上升至2014年(86.2),此后保持不变(即2017年为86.5)。在研究期间,睾丸癌、男女性皮肤黑色素瘤和甲状腺癌的发病率在 2013 年之前一直呈上升趋势(2014 年至 2017 年略有下降)。相反,结直肠癌的ASR持续下降,子宫颈癌(从8.1降至7.7)、卵巢癌(从7.5降至6.9)和非霍奇金淋巴瘤(男性从8.3降至7.6,女性从5.9降至5.5)的ASR基本稳定或略有下降:研究结果并不像其他国家报告的那样,支持意大利早发性癌症发病率在 2017 年之前的独特时间模式。在某些肿瘤部位,男女发病率的增长被其他部位发病率的下降所抵消。必须强调从最小年龄开始支持预防战略的重要性,并应认真对待预期筛查的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-2017.

Objective: To evaluate short-term (2008-2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and cancer type.

Methods: Observational study from population-based data collected by 20 Italian Cancer Registries, covering 33% of the Italian population. The age-standardized incidence rates (ASRs), overall and stratified by area, sex, cancer site or type, and major age groups (i.e., 20-39, 40-49), were computed.

Results: In 2008-2017, cancer incidence rates were almost two times higher in Italian women aged 20-49 than in age-corresponding men (202.2 vs 112.4 per 100,000) on account of elevated rates of breast and thyroid cancers. Contrasting trends emerged according to cancer sites/types. ASRs for female breast cancer increased steadily from 2008 (82.4) to 2014 (86.2) and remained unchanged thereafter (i.e., 86.5 in 2017). During the study period, there was an increase for testicular cancer, skin melanoma in both sexes, and thyroid cancer until 2013 (followed by a slight decrease from 2014 to 2017). Conversely, ASRs consistently declined for colorectal cancer and were substantially stable or slightly decreasing for cervix uteri (from 8.1 to 7.7), ovary (from 7.5 to 6.9) and non-Hodgkin lymphoma (from 8.3 to 7.6 in men and from 5.9 to 5.5 in women).

Conclusions: Study findings do not support a unique temporal pattern for the incidence of early-onset cancer in Italy until 2017, as reported in other countries. Increases in incidence documented in both sexes for some tumor sites was counterbalanced by a decrease in other sites. The importance of supporting prevention strategies from the youngest of ages must be emphasized, and the role of anticipated screening should be carefully addressed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Tumori
Tumori 医学-肿瘤学
CiteScore
3.50
自引率
0.00%
发文量
58
审稿时长
6 months
期刊介绍: Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信